- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05618158
Cancer Prevention for Young Rural Adults
December 24, 2025 updated by: Klein Buendel, Inc.
#4Corners4Health: A Social Media Cancer Prevention Program for Rural Emerging Adults
Young adults aged 18-26 engage in a number of behaviors that increase their risk of developing cancer later in life including sedentary lifestyles, unhealthy eating, nicotine produce us, heavy drinking of alcohol, increased UV exposure, and incomplete uptake of HPV vaccination.
A multi-risk factor campaign will be developed to reduce these cancer risk behaviors and delivered to young adults over social media, a popular channel that can reach nearly all young adults.
The campaign will be evaluated for effectiveness in a rigorous randomized trial with measures of moderate to vigorous physical activity, healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination uptake.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Several risk factors are prevalent during early adulthood that can lead to cancer later in life.
Emerging adults (EAs) aged 18-26 residing in rural areas of the United States engage in many cancer risk behaviors, especially sedentary lifestyles, poor eating patterns, nicotine product use, excess alcohol intake, infrequent sun protection, and inadequate uptake of the HPV vaccine.
This application responds to RFA-CA-20-051, "Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations."
The goal is to improve cancer risk behavioral factors among diverse EAs aged 18-26 living in rural counties in the Four Corners states, a unique, underserved region, using a social media campaign designed with community advisors.
EAs, including in rural communities, are heavy consumers of online content, especially over social media, and social media provide responsive, engaging, and low-cost platforms for distributing cancer prevention information with high dissemination potential.
But, social media also circulate inaccurate, misleading, and harmful information.
The specific aims of this research are to: 1) Develop a social media intervention for diverse EAs in rural communities via a community-engaged process that combines expert advice, user-generated content, and online instruction to communicate about behavioral cancer risks, cancer misinformation, counter marketing, digital and media literacy, and family communication; 2) evaluate the effect of a theory-based social media intervention on moderate to vigorous physical activity (MVPA), healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination with the diverse population of EAs aged 18-26 in rural counties in AZ, CO, NM, and UT (Four Corners states) recruited from Qualtrics' survey panel and enrolled in a pragmatic randomized trial using a stepped-wedge design in which individual EAs will be randomized to 1 of 4 cohorts and receive the social media feed for varying durations in separate Facebook private groups; 3) test if improvements in EAs' cancer risk knowledge and beliefs, digital and media literacy skills, accurate cancer prevention information, and family communication mediate impact of the social media campaign; and 4) explore whether the impact of the social media campaign differs according to: a) level of EAs' engagement with campaign, b) cancer risk factors, and c) biological sex of the participants (as required by NIH).
The research is innovative because it tests a theory-based, multi-risk factor approach to cancer prevention with diverse EAs in rural counties, an under-studied population, in a very popular new media.
Social media may reach EAs more than interventions through other community channels (e.g., clinics, schools, and workplaces) and for lower cost in the geographically-dispersed, underserved rural communities in the Mountain West.
The overall impact is extremely high because it will aid rural EAs in making informed decisions that reduce cancer risk factors and prevent cancer later in life and help EAs critically evaluate and resist misinformation and marketing that promote cancer risk behaviors.
Study Type
Interventional
Enrollment (Actual)
1796
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85719
- University of Arizona
-
-
Colorado
-
Aurora, Colorado, United States, 80045-2570
- University of Colorado Denver
-
Fort Collins, Colorado, United States, 80521-4593
- Colorado State University
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131-0001
- University of New Mexico
-
-
Utah
-
Salt Lake City, Utah, United States, 84112-5550
- University of Utah
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 22 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Aged 18-26 years old
- Resides in a county coded as RUCC 4-9 in Arizona, Colorado, New Mexico, or Utah
- Able to speak and read English
- Has regular social media engagement
- Accepts screening call from study staff
- Consents to participate
Exclusion Criteria:
- Participated in community engagement activities
- Cannot speak and read English
- Has low or no social media engagement
- Does not accept a screening call from study staff
- Does not consent to participate
- Does not give permission for engagement data to be extracted from Facebook private group
- If biologically female, currently pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 4 Corners Rural Cancer Prevention
Four separate Facebook groups, which provide information via posts within the private groups about cancer risk factors (e.g.
reducing alcohol consumption, tobacco use cessation, increasing physical activity), behavioral skills to reduce them, benefits of, social support for, and ways to reduce social/financial costs of cancer prevention, and advice from health care providers to decrease barriers.
Posts will seek to improve self- and response-efficacy and perceived risk, and link cancer prevention to personal goals.
|
Participants, aged 18-26, will join a private Facebook group to participate in the intervention.
The group is not viewable to the public, including other Facebook users.
Content that focuses on cancer prevention behaviors will be posted twice per day for up to 12 months.
Each group will be hosted by a moderator who is responsible for managing the intervention goals and participants' engagement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Activity
Time Frame: Baseline
|
Participants will self-report minutes per week of moderate to vigorous physical activity.
|
Baseline
|
|
Physical Activity
Time Frame: 3 months
|
Participants will self-report minutes per week of moderate to vigorous physical activity.
|
3 months
|
|
Physical Activity
Time Frame: 12 months
|
Participants will self-report minutes per week of moderate to vigorous physical activity.
|
12 months
|
|
Physical Activity
Time Frame: 24 months
|
Participants will self-report minutes per week of moderate to vigorous physical activity.
|
24 months
|
|
Diet
Time Frame: Baseline
|
Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.
|
Baseline
|
|
Diet
Time Frame: 3 months
|
Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.
|
3 months
|
|
Diet
Time Frame: 12 months
|
Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.
|
12 months
|
|
Diet
Time Frame: 24 months
|
Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.
|
24 months
|
|
Nicotine Product Use
Time Frame: Baseline
|
Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).
|
Baseline
|
|
Nicotine Product Use
Time Frame: 3 months
|
Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).
|
3 months
|
|
Nicotine Product Use
Time Frame: 12 months
|
Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).
|
12 months
|
|
Nicotine Product Use
Time Frame: 24 months
|
Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).
|
24 months
|
|
Alcohol Intake
Time Frame: Baseline
|
Participants self-report consumption of number of alcoholic drinks in the past 30 days.
|
Baseline
|
|
Alcohol Intake
Time Frame: 3 months
|
Participants self-report consumption of number of alcoholic drinks in the past 30 days.
|
3 months
|
|
Alcohol Intake
Time Frame: 12 months
|
Participants self-report consumption of number of alcoholic drinks in the past 30 days.
|
12 months
|
|
Alcohol Intake
Time Frame: 24 months
|
Participants self-report consumption of number of alcoholic drinks in the past 30 days.
|
24 months
|
|
Uv Exposure
Time Frame: Baseline
|
Participants will self-report number of sunburns.
|
Baseline
|
|
Uv Exposure
Time Frame: 3 months
|
Participants will self-report number of sunburns.
|
3 months
|
|
Uv Exposure
Time Frame: 12 months
|
Participants will self-report number of sunburns.
|
12 months
|
|
Uv Exposure
Time Frame: 24 months
|
Participants will self-report number of sunburns.
|
24 months
|
|
HPV Vaccination
Time Frame: Baseline
|
Participants will self-report whether or not they have received one or more doses of the HPV vaccine.
|
Baseline
|
|
HPV Vaccination
Time Frame: 3 months
|
Participants will self-report whether or not they have received one or more doses of the HPV vaccine.
|
3 months
|
|
HPV Vaccination
Time Frame: 12 months
|
Participants will self-report whether or not they have received one or more doses of the HPV vaccine.
|
12 months
|
|
HPV Vaccination
Time Frame: 24 months
|
Participants will self-report whether or not they have received one or more doses of the HPV vaccine.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Activity
Time Frame: Baseline
|
Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.
|
Baseline
|
|
Physical Activity
Time Frame: 3 months
|
Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.
|
3 months
|
|
Physical Activity
Time Frame: 12 months
|
Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.
|
12 months
|
|
Physical Activity
Time Frame: 24 months
|
Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.
|
24 months
|
|
Diet
Time Frame: Baseline
|
Participants will self-report frequency of eating meals away from home/fast food.
|
Baseline
|
|
Diet
Time Frame: 3 months
|
Participants will self-report frequency of eating meals away from home/fast food.
|
3 months
|
|
Diet
Time Frame: 12 months
|
Participants will self-report frequency of eating meals away from home/fast food.
|
12 months
|
|
Diet
Time Frame: 24 months
|
Participants will self-report frequency of eating meals away from home/fast food.
|
24 months
|
|
Nicotine Product Use
Time Frame: Baseline
|
Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).
|
Baseline
|
|
Nicotine Product Use
Time Frame: 3 months
|
Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).
|
3 months
|
|
Nicotine Product Use
Time Frame: 12 months
|
Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).
|
12 months
|
|
Nicotine Product Use
Time Frame: 24 months
|
Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).
|
24 months
|
|
Nicotine Product Use
Time Frame: Baseline
|
Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).
|
Baseline
|
|
Nicotine Product Use
Time Frame: 3 months
|
Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).
|
3 months
|
|
Nicotine Product Use
Time Frame: 12 months
|
Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).
|
12 months
|
|
Nicotine Product Use
Time Frame: 24 months
|
Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).
|
24 months
|
|
Alcohol Intake
Time Frame: Baseline
|
Participants will self-report number of times binge drinking in the past 30 days.
|
Baseline
|
|
Alcohol Intake
Time Frame: 3 months
|
Participants will self-report number of times binge drinking in the past 30 days.
|
3 months
|
|
Alcohol Intake
Time Frame: 12 months
|
Participants will self-report number of times binge drinking in the past 30 days.
|
12 months
|
|
Alcohol Intake
Time Frame: 24 months
|
Participants will self-report number of times binge drinking in the past 30 days.
|
24 months
|
|
UV Exposure
Time Frame: Baseline
|
Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.
|
Baseline
|
|
UV Exposure
Time Frame: 3 months
|
Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.
|
3 months
|
|
UV Exposure
Time Frame: 12 months
|
Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.
|
12 months
|
|
UV Exposure
Time Frame: 24 months
|
Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.
|
24 months
|
|
HPV Vaccination
Time Frame: Baseline
|
Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.
|
Baseline
|
|
HPV Vaccination
Time Frame: 3 months
|
Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.
|
3 months
|
|
HPV Vaccination
Time Frame: 12 months
|
Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.
|
12 months
|
|
HPV Vaccination
Time Frame: 24 months
|
Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: David Buller, PhD, Klein Buendel, Inc.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 20, 2024
Primary Completion (Actual)
August 31, 2025
Study Completion (Actual)
August 31, 2025
Study Registration Dates
First Submitted
November 8, 2022
First Submitted That Met QC Criteria
November 8, 2022
First Posted (Actual)
November 16, 2022
Study Record Updates
Last Update Posted (Actual)
December 26, 2025
Last Update Submitted That Met QC Criteria
December 24, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0341/0353
- 1R01CA268037-01A1 (U.S. NIH Grant/Contract)
- 4R01CA268037-04 (U.S. NIH Grant/Contract)
- 5R01CA268037-03 (U.S. NIH Grant/Contract)
- 5R01CA268037-02 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
Clinical Trials on 4 Corners Rural Health Cancer Prevention
-
Universidad Miguel Hernandez de ElcheUniversidad de Murcia; Erasmus Medical Center; Thomas More University of Applied... and other collaboratorsNot yet recruitingProstate Cancer | Health LiteracySpain
-
Ahvaz Jundishapur University of Medical SciencesCompletedPromoting Skin Cancer Protective BehaviorsIran, Islamic Republic of
-
Xavier University of Louisiana.Active, not recruitingPrediabetes | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Prediabetic State &Amp; High Risk Individuals on the Basis of Diabetes Risk ScoreUnited States
-
Centers for Disease Control and PreventionColorado Department of Public Health and Environment; San Francisco Department... and other collaboratorsCompletedSexually Transmitted Diseases | HIV
-
Castilla-La Mancha Health ServiceColegio Oficial de Terapeutas Ocupacionales de Castilla - La Mancha; Fundación... and other collaboratorsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterThe City College of New York; Queens Cancer Center of Queens Hospital; New York... and other collaboratorsActive, not recruitingAdvanced CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Texas Southwestern Medical Center; Wake Forest UniversityActive, not recruitingBreast CancerUnited States
-
Hospices Civils de LyonNot yet recruiting
-
Jonsson Comprehensive Cancer CenterVarian Medical SystemsRecruitingRecurrent Head and Neck Carcinoma | Head and Neck Carcinoma | Metastatic Head and Neck Carcinoma | Localized Head and Neck CarcinomaUnited States
-
Weill Medical College of Cornell UniversityThe New York Community TrustCompletedHeart Failure | Heart Disease | Heart Failure, Diastolic | Heart Failure With Preserved Ejection Fraction | Cardiac FailureUnited States